Abbott's MitraClip Approved in Canada

Abbott (NYSE: ABT) has announced that its MitraClip Delivery System has been approved in Canada for use in patients "with degenerative mitral regurgitation who are too high risk for mitral valve surgery based on evaluation by a team of heart doctors, including a heart surgeon." The ruling by Health Canada now allows sale of the MitraClip throughout the country; the MitraClip was approved by the FDA for use in the United States last October.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news